DNAJB6P2

Across TCGA pan-cancer cohorts, DNAJB6P2 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated DNAJB6P2 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher DNAJB6P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJB6P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and KIRP show a favorable association.

KICH, HNSC, and OV are the cancer types where DNAJB6P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Quartile	II,III,IV	0.412	0.951	<.001	87	view →
HNSC	DFS	Median	II,III,IV	0.432	0.239	<.001	87	view →
OV	OS	Tertile	All	0.250	0.391	<.001	66	view →
LIHC	OS	Tertile	II,III,IV	0.435	0.751	<.001	54	view →
MESO	OS	Median	All	0.192	0.379	.002	40	view →
STAD	DFS	Quartile	II,III,IV	0.220	0.497	.003	38	view →
BLCA	DFS	Quartile	All	0.532	0.643	.009	31	view →
CESC	DFS	Tertile	All	0.340	0.620	<.001	30	view →
THCA	OS	Tertile	III,IV	0.884	1.000	.002	14	view →
KIRP	DFS	Tertile	All	1.000	0.661	.005	12	view →
LAML	DFS	Quartile	All	0.757	0.436	.027	12	view →
LUAD	OS	Tertile	III,IV	0.268	0.547	.003	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

DNAJB6P2–KICH (DFS)

Open the KICH breakdown →